• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破骨细胞来源的核因子-κB 受体活化因子配体在小鼠卵巢切除诱导的骨丢失中的作用。

Role of Mast-Cell-Derived RANKL in Ovariectomy-Induced Bone Loss in Mice.

机构信息

Institute of Orthopedic Research and Biomechanics, University Medical Center Ulm, 89081 Ulm, Germany.

Institute for Molecular and Clinical Immunology, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany.

出版信息

Int J Mol Sci. 2023 May 23;24(11):9135. doi: 10.3390/ijms24119135.

DOI:10.3390/ijms24119135
PMID:37298085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10252757/
Abstract

Mast cells may contribute to osteoporosis development, because patients with age-related or post-menopausal osteoporosis exhibit more mast cells in the bone marrow, and mastocytosis patients frequently suffer from osteopenia. We previously showed that mast cells crucially regulated osteoclastogenesis and bone loss in ovariectomized, estrogen-depleted mice in a preclinical model for post-menopausal osteoporosis and found that granular mast cell mediators were responsible for these estrogen-dependent effects. However, the role of the key regulator of osteoclastogenesis, namely, receptor activator of NFκB ligand (RANKL), which is secreted by mast cells, in osteoporosis development has, to date, not been defined. Here, we investigated whether mast-cell-derived RANKL participates in ovariectomy (OVX)-induced bone loss by using female mice with a conditional deletion. We found that this deletion in mast cells did not influence physiological bone turnover and failed to protect against OVX-induced bone resorption in vivo, although we demonstrated that RANKL secretion was significantly reduced in estrogen-treated mast cell cultures. Furthermore, deletion in mast cells did not influence the immune phenotype in non-ovariectomized or ovariectomized mice. Therefore, other osteoclastogenic factors released by mast cells might be responsible for the onset of OVX-induced bone loss.

摘要

肥大细胞可能有助于骨质疏松症的发展,因为与年龄相关或绝经后骨质疏松症患者的骨髓中有更多的肥大细胞,肥大细胞增多症患者经常患有骨质疏松症。我们之前的研究表明,在绝经后骨质疏松症的临床前模型中,肥大细胞在卵巢切除、雌激素缺乏的小鼠中对破骨细胞生成和骨丢失具有重要的调节作用,并且发现颗粒肥大细胞介质是这些雌激素依赖性作用的原因。然而,到目前为止,尚未确定肥大细胞分泌的破骨细胞生成关键调节剂,即核因子-κB 配体(RANKL)在骨质疏松症发展中的作用。在这里,我们通过使用条件性缺失的雌性小鼠来研究肥大细胞衍生的 RANKL 是否参与卵巢切除(OVX)诱导的骨丢失。我们发现,这种肥大细胞中的缺失并不影响生理骨转换,并且不能在体内预防 OVX 诱导的骨吸收,尽管我们证明了雌激素处理的肥大细胞培养物中 RANKL 的分泌显着减少。此外,肥大细胞中的缺失并不影响非卵巢切除或卵巢切除小鼠的免疫表型。因此,肥大细胞释放的其他破骨细胞生成因子可能是导致 OVX 诱导的骨丢失的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/a51aeeac83b9/ijms-24-09135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/418fe712d4d0/ijms-24-09135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/421ec7bc99e8/ijms-24-09135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/c5905155d22d/ijms-24-09135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/0c993cbf2879/ijms-24-09135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/a51aeeac83b9/ijms-24-09135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/418fe712d4d0/ijms-24-09135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/421ec7bc99e8/ijms-24-09135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/c5905155d22d/ijms-24-09135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/0c993cbf2879/ijms-24-09135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec8/10252757/a51aeeac83b9/ijms-24-09135-g005.jpg

相似文献

1
Role of Mast-Cell-Derived RANKL in Ovariectomy-Induced Bone Loss in Mice.破骨细胞来源的核因子-κB 受体活化因子配体在小鼠卵巢切除诱导的骨丢失中的作用。
Int J Mol Sci. 2023 May 23;24(11):9135. doi: 10.3390/ijms24119135.
2
Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.白杨素 A 通过抑制 NF-κB 和 Akt 通路抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨质疏松症。
J Ethnopharmacol. 2021 Aug 10;276:114176. doi: 10.1016/j.jep.2021.114176. Epub 2021 Apr 30.
3
Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.氢气通过抑制 NF-κB 激活来预防去卵巢诱导的骨质疏松症。
Menopause. 2019 Jul;26(7):785-792. doi: 10.1097/GME.0000000000001310.
4
Cumambrin A prevents OVX-induced osteoporosis the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways.大麻素受体调节剂 A 可预防去卵巢诱导的骨质疏松症,其作用机制可能与抑制破骨细胞生成、骨吸收以及核因子-κB 受体活化因子配体信号通路有关。
FASEB J. 2019 Jun;33(6):6726-6735. doi: 10.1096/fj.201800883RRR. Epub 2019 Feb 26.
5
The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.天然小分子化合物蛇床子素通过抑制破骨细胞分化来预防去卵巢诱导的小鼠骨丢失。
Menopause. 2018 Dec;25(12):1459-1469. doi: 10.1097/GME.0000000000001150.
6
Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.佛手柑内酯通过抑制 NF-κB 和 JNK 信号通路抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨质疏松症。
Biochem Biophys Res Commun. 2019 Feb 5;509(2):329-334. doi: 10.1016/j.bbrc.2018.12.112. Epub 2018 Dec 20.
7
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice.PRMT1 介导 RANKL 诱导的破骨细胞生成,并促进去卵巢小鼠的骨丢失。
Exp Mol Med. 2018 Aug 28;50(8):1-15. doi: 10.1038/s12276-018-0134-x.
8
Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.穿心莲内酯通过抑制RANKL信号通路抑制去卵巢诱导的骨质流失。
Int J Mol Sci. 2015 Nov 17;16(11):27470-81. doi: 10.3390/ijms161126039.
9
Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.茶多糖抑制 RAW264.7 细胞中 RANKL 诱导的破骨细胞生成,并改善去卵巢大鼠骨质疏松症。
Biomed Pharmacother. 2018 Jun;102:539-548. doi: 10.1016/j.biopha.2018.03.125. Epub 2018 Apr 5.
10
Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.前列腺素E2诱导前B细胞上核因子κB受体激活剂配体/骨保护素配体的表达:对雌激素缺乏时破骨细胞生成加速的影响。
J Bone Miner Res. 2000 Jul;15(7):1321-9. doi: 10.1359/jbmr.2000.15.7.1321.

引用本文的文献

1
Mast Cells in Human Health and Diseases 2.0.人类健康与疾病中的肥大细胞 2.0.
Int J Mol Sci. 2024 Jun 11;25(12):6443. doi: 10.3390/ijms25126443.

本文引用的文献

1
Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis.成骨细胞上的补体受体 C5aR1 调节实验性绝经后骨质疏松症中的破骨细胞生成。
Front Endocrinol (Lausanne). 2022 Sep 30;13:1016057. doi: 10.3389/fendo.2022.1016057. eCollection 2022.
2
Human mast cells induce osteoclastogenesis through cell surface RANKL.人源肥大细胞通过细胞表面 RANKL 诱导破骨细胞生成。
Inflamm Res. 2022 Nov;71(10-11):1261-1270. doi: 10.1007/s00011-022-01608-9. Epub 2022 Aug 2.
3
New perspectives on the origins and heterogeneity of mast cells.
肥大细胞起源与异质性的新视角。
Nat Rev Immunol. 2023 Jan;23(1):55-68. doi: 10.1038/s41577-022-00731-2. Epub 2022 May 24.
4
Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice.肥大细胞在骨质疏松症小鼠中引发骨愈合紊乱。
J Bone Miner Res. 2022 Jan;37(1):137-151. doi: 10.1002/jbmr.4455. Epub 2021 Oct 21.
5
SCOPE 2021: a new scorecard for osteoporosis in Europe.《2021年欧洲骨质疏松症评分指南》:欧洲骨质疏松症的新记分卡
Arch Osteoporos. 2021 Jun 2;16(1):82. doi: 10.1007/s11657-020-00871-9.
6
Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.骨骼与免疫细胞之间的相互作用:对绝经后骨质疏松症的影响。
Semin Cell Dev Biol. 2022 Mar;123:14-21. doi: 10.1016/j.semcdb.2021.05.014. Epub 2021 May 20.
7
Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis.类风湿关节炎中肥大细胞对破骨细胞生成的调控。
Arthritis Res Ther. 2021 Apr 21;23(1):124. doi: 10.1186/s13075-021-02491-1.
8
Mast cells contribute to alveolar bone loss in Spontaneously Hypertensive Rats with periodontal disease regulating cytokines production.肥大细胞促进牙周病伴自发性高血压大鼠肺泡骨丢失及细胞因子的产生。
PLoS One. 2021 Mar 4;16(3):e0247372. doi: 10.1371/journal.pone.0247372. eCollection 2021.
9
Increased systemic inflammation and altered distribution of T-cell subsets in postmenopausal women.绝经后女性全身炎症增加及T细胞亚群分布改变。
PLoS One. 2020 Jun 23;15(6):e0235174. doi: 10.1371/journal.pone.0235174. eCollection 2020.
10
RANK Ligand Helps Immunity to by Skewing M2-Like Into M1 Macrophages.RANK Ligand 有助于通过将 M2 样巨噬细胞向 M1 巨噬细胞倾斜来抵抗 。
Front Immunol. 2020 May 12;11:886. doi: 10.3389/fimmu.2020.00886. eCollection 2020.